Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy
Authors:
- B TeichmannBTB Teichmann
- R HormesRHR Hormes
- D GrimmDGD Grimm
- J KleinschmidtJKJ Kleinschmidt
- G SczakielGSG Sczakiel
- 1 July 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (7) , 1231-1238
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 33 references indexed in Scilit:
- Recombinant Adeno-Associated Virus for the Generation of Autologous, Gene-Modified Tumor Vaccines: Evidence for a High Transduction Efficiency into Primary Epithelial Cancer CellsHuman Gene Therapy, 1998
- The packaging capacity of adeno‐associated virus (AAV) and the potential for wild‐type‐plus AAV gene therapy vectorsFEBS Letters, 1997
- Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promotersGene Therapy, 1997
- Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated VirusHuman Gene Therapy, 1996
- Effects of Gamma Irradiation on the Transduction of Dividing and Nondividing Cells in Brain and Muscle of Rats by Adeno-Associated Virus VectorsHuman Gene Therapy, 1996
- Recombinant adeno-associated virus (rAAV)-mediated expression of a human gamma-globin gene in human progenitor-derived erythroid cells.Proceedings of the National Academy of Sciences, 1994
- Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainNature Genetics, 1994
- Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.Proceedings of the National Academy of Sciences, 1993
- Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1Nucleic Acids Research, 1993
- Identification and analysis of antisense RNA target regions of the human immunodeficiency virus type 1Nucleic Acids Research, 1991